BFM
IOVA icon

Boothbay Fund Management’s Iovance Biotherapeutics IOVA Stock Holding History

Boothbay Fund Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-50,000
Closed -$167K – 1648
2025
Q1 		$167K Buy
+50,000
New +$258K 0.01% 1192
2024
Q4 		– Hold
0
– – – 1747
2024
Q3 		– Hold
0
– – – 1803
2024
Q2 		– Hold
0
– – – 1721
2024
Q1 		– Hold
0
– – – 1779
2022
Q1 		– Sell
-17,366
Closed -$332K – 2442
2021
Q4 		$332K Sell
17,366
-5,808
-25% -$128K 0.01% 1211
2021
Q3 		$571K Sell
23,174
-597
-3% -$14.1K 0.02% 1025
2021
Q2 		$619K Buy
+23,771
New +$618K 0.02% 910
2021
Q1 		– Hold
0
– – – 1697
2017
Q3 		– Sell
-16,746
Closed -$123K – 696
2017
Q2 		$123K Buy
+16,746
New +$106K 0.03% 604

Other funds holding IOVA

MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $2.28B AUM 7.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.17B AUM 0.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return